Effect of prostavasin in patients with limb ischemia
Phase 2
- Conditions
- critical limb ischemia.Atherosclerosis of arteries of extremities
- Registration Number
- IRCT201207292220N4
- Lead Sponsor
- Research Deputy, Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
All patients with rest pain;limb ulcer;gangrene related to arterial occlusive disease who can not tolerat surgery ;and vascular anatomy were unsuitable for reconstruction.enrolled in the study.
Exclusion criteria: patients rest pain;limb ulcer;gangrene related to arterial occlusive disease who have tolerated the surgery; and vascular anatomy were suitable for reconstruction, were excluded in the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ankle-brachial index. Timepoint: at presentation, 2 weeks, one month, and three months after the administration. Method of measurement: color doppler sonograghy.;Rest pain. Timepoint: 2 weeks, one month, and three months after the administration. Method of measurement: history and physical examination.;Healing of ulcer. Timepoint: 2 weeks, one month, and three months after the administration. Method of measurement: history and physical examination.;Gangrene. Timepoint: 2 weeks, one month, and three months after the administration. Method of measurement: history and physical examination.
- Secondary Outcome Measures
Name Time Method eed to amputation. Timepoint: 2 weeks, one month, and three months after the administration. Method of measurement: history and physical examination.